Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedShort-Term Debt repayments
Ratios

Mangoceuticals (MGRX) Accumulated Depreciation & Amortization (2023 - 2025)

Mangoceuticals' Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $758.0 for Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization fell 92.17% year-over-year to $758.0; the TTM value through Sep 2025 reached $758.0, down 92.17%, while the annual FY2024 figure was $9936.0, 60.08% down from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2025 was $758.0 at Mangoceuticals, up from $502.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $24889.0 in Q4 2023 and bottomed at -$109874.0 in Q1 2023.
  • The 3-year median for Accumulated Depreciation & Amortization is $6224.0 (2024), against an average of -$2430.1.
  • The largest annual shift saw Accumulated Depreciation & Amortization skyrocketed 105.66% in 2024 before it tumbled 95.98% in 2025.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $24889.0 in 2023, then crashed by 60.08% to $9936.0 in 2024, then crashed by 92.37% to $758.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Accumulated Depreciation & Amortization are $758.0 (Q3 2025), $502.0 (Q2 2025), and $250.0 (Q1 2025).